Foot and Mouth Disease National Reference Laboratory - 2021 |
|
|---|---|
|
State Department |
|
|
Programme |
|
|
Sub Programme |
|
|
Allocation: |
KES 24,226,077.00 (R) |
Key Performance Indicators
Key Output |
KPI |
Target Yr (2021) |
Target Yr (2022) |
Target Yr (2023) |
|---|---|---|---|---|
|
Effective drugs and vaccines |
Number of samples analysed |
6500 |
7500 |
7500 |
|
Effective drugs and vaccines |
Number of FMD vaccine batches tested |
10 |
10 |
10 |
Previous Year Allocations
Num |
Year |
Recurrent |
Development |
Total |
|---|---|---|---|---|
|
1 |
KES 24,226,077.00 |
KES 0.00 |
KES 24,226,077.00 |
|
|
2 |
KES 24,810,852.00 |
KES 0.00 |
KES 24,810,852.00 |
|
|
3 |
KES 25,079,774.00 |
KES 0.00 |
KES 25,079,774.00 |
|
|
4 |
KES 31,347,473.00 |
KES 0.00 |
KES 31,347,473.00 |